Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Sodium channel protein type 9 subunit alpha | ||
Ligand | BDBM145254 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | Electrophysiological Assay (In Vitro Assay) | ||
IC50 | 93.7±n/a nM | ||
Citation | Chowdhury, S; Dehnhardt, CM; Focken, T; Grimwood, ME; Hemeon, IW; Jia, Q; Ortwine, DF; Safina, B; Sun, S; Sutherlin, DP; Zenova, AY N-substituted benzamides and methods of use thereof US Patent US9771376 Publication Date 9/26/2017 | ||
More Info.: | Get all data from this article, Assay Method | ||
Sodium channel protein type 9 subunit alpha | |||
Name: | Sodium channel protein type 9 subunit alpha | ||
Synonyms: | NENA | Neuroendocrine sodium channel | Peripheral sodium channel 1 | SCN9A | SCN9A_HUMAN | Sodium channel protein type IX alpha subunit | Voltage-gated sodium channel subunit Nav1.7 | Voltage-gated sodium channel subunit alpha Nav1.7 | hNE-Na | ||
Type: | Protein | ||
Mol. Mass.: | 226375.97 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Q15858 | ||
Residue: | 1988 | ||
Sequence: |
| ||
BDBM145254 | |||
n/a | |||
Name | BDBM145254 | ||
Synonyms: | US8952169, 33 | US9771376, Example 33 | ||
Type | Small organic molecule | ||
Emp. Form. | C19H24ClFN2O4S | ||
Mol. Mass. | 430.921 | ||
SMILES | CN(C)S(=O)(=O)NC(=O)c1cc(Cl)c(OC2C3CC4CC(C3)CC2C4)cc1F |TLB:14:15:17:19.20.21,THB:15:23:19:17.16.21,15:16:19:23.22.24,22:23:17:19.20.21,22:20:17:23.15.24,(7.75,-1.15,;6.42,-1.93,;6.42,-3.47,;5.08,-1.15,;4.31,-2.49,;5.85,.18,;3.75,-.38,;2.41,-1.15,;2.41,-2.7,;1.08,-.38,;1.08,1.16,;-.25,1.93,;-.25,3.47,;-1.59,1.15,;-2.92,1.93,;-4.25,1.15,;-5.58,1.92,;-6.92,1.15,;-6.92,-.38,;-7.75,-2.29,;-6.35,-1.64,;-6.34,.76,;-5.15,-2.31,;-4.25,-.38,;-5.58,-1.16,;-1.59,-.38,;-.25,-1.15,;-.25,-2.7,)| | ||
Structure |